U.S. Congress - S.501 Fair Prescription Drug Competition Act
S.501 - Fair Prescription Drug Competition Act
A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. view all titles (2)
All Bill Titles
- Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. as introduced.
- Short: Fair Prescription Drug Competition Act as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Bill's Views
- Today: 4
- Past Seven Days: 12
- All-Time: 2,381
|
|
|
|
|
|
|
|
Official Summary
2/26/2009--Introduced.Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt ofOfficial Summary
2/26/2009--Introduced.Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer....Read the Rest
Vote on This Bill
-
Share This Bill
More Share via Email
